Baseline clinical features but not TLL1 variants predicts HCC onset in Caucasian compensated HBV cirrhotics treated by Entecavir or Tenofovir for 8 years. Issue 1 (February 2018) - Loglio, A.; Galmozzi, E.; Iavarone, M.; Grossi, G.; Viganò, M.; Facchetti, F.; Perbellini, R.; Rumi, M.G.; Sangiovanni, A.; Lampertico, P.